ALX ONCOLOGY HOLDINGS INC Quarterly Debt-to-equity in % from Q1 2021 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Alx Oncology Holdings Inc quarterly Debt-to-equity history and growth rate from Q1 2021 to Q4 2024.
Alx Oncology Holdings Inc Debt-to-equity for the quarter ending December 31, 2024 was 32.6 %, a 50.8% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	32.6	+11	+50.8%	Dec 31, 2024
Q3 2024	31.6	+12.9	+69.3%	Sep 30, 2024
Q2 2024	30.5	+16.1	+111%	Jun 30, 2024
Q1 2024	25.3	+12.5	+98.2%	Mar 31, 2024
Q4 2023	21.6	+11.4	+112%	Dec 31, 2023
Q3 2023	18.7	+11.2	+151%	Sep 30, 2023
Q2 2023	14.4	+8.64	+149%	Jun 30, 2023
Q1 2023	12.8	+8.21	+181%	Mar 31, 2023
Q4 2022	10.2	+6.24	+157%	Dec 31, 2022
Q3 2022	7.45	+4.31	+137%	Sep 30, 2022
Q2 2022	5.79	+2.64	+83.9%	Jun 30, 2022
Q1 2022	4.55	+0.26	+6.07%	Mar 31, 2022
Q4 2021	3.97			Dec 31, 2021
Q3 2021	3.14			Sep 30, 2021
Q2 2021	3.14			Jun 30, 2021
Q1 2021	4.29			Mar 31, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.